FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc

Bullboard Posts

Post by THCbeverageson Apr 25, 2019 8:07am

234 Views

Post# 29668168

Breaking down the numbers...STILL UNDERVALUED!!!

-Current Bottling Equipment: 250,000 bottles per month
-Permanent Bottling Equipment coming in late Q2: 1,000,000 bottles per month
-Total combined once both lines are running: 1,250,000 bottles per month

-Wholesale price is $3-4USD for single serve and $15-17USD for T27 line

-Potential revenue once fully operational --> 1,250,000 x $3-$17 = $3.8 - $21.3USD Million per month - -> Median is $12.55USD Million per month

-Potential annual revenue --> $150.6 Million USD = $201.8 Million CAD

-Current Shares Outstanding --> 91,427, 034
-Current Market Cap --> $79 Million CAD

GIGANTIC INVESTMENT RETURN POTENTIAL.

Company Corporate Presentation

Bullboard Posts

The Market Online’s Weekly Gold Report – July 3, 2024